| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.6M | +71.4% |
| R&D Expense | $110.6M | -6.0% |
| SG&A Expense | $42.1M | +0.1% |
| Operating Income | -$119.6M | +14.0% |
| Pre-tax Income | -$105.2M | +19.8% |
| Income Tax | $131K | -89.8% |
| Net Income | -$105.3M | +20.5% |
| EPS (Basic) | -$1.52 | +43.1% |
| EPS (Diluted) | -$1.52 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.5M | -56.2% |
| Accounts Receivable | $3.1M | -73.7% |
| Current Assets | $257.8M | -4.9% |
| Total Assets | $349.6M | -7.1% |
| Current Liabilities | $45.2M | +5.6% |
| Total Liabilities | $133.6M | +2.5% |
| Stockholders' Equity | $216.0M | -12.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.2M | +39.0% |
| Capital Expenditures | $180K | -89.5% |
| Investing Cash Flow | -$51.3M | -132.4% |
| Financing Cash Flow | $45.3M | -0.3% |
| Free Cash Flow | -$65.3M | +39.8% |
| +43.1% |